Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Maria Rivas-Grajales

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Chronic Stress (Thousand Oaks, Calif.)|July 6, 2019
"Does the opioid system block or enhance the antidepressant effects of ketamine?"Sanjay J Mathew, Ana Maria Rivas-Grajales
CNS Spectrums|June 21, 2016
Psychosis of epilepsy: a multifaceted neuropsychiatric disorderAndres M Kanner, Ana Maria Rivas-Grajales
Expert Opinion on Investigational Drugs|October 15, 2019
Novel investigational therapeutics for generalized anxiety disorder (GAD)Bella Schanzer, Ana Maria Rivas-Grajales, Aamir Khan, et al.
Harvard Review of Psychiatry|May 12, 2023
The Impact of Sex Hormones on Transcranial Magnetic Stimulation Measures of Cortical Excitability: A Systematic Review and Considerations for Clinical PracticeAna Maria Rivas-Grajales, Tracy Barbour, Joan A Camprodon, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 10, 2025
L266V <i>MAPT</i> Gene Mutation Associated With Frontotemporal Dementia, Progressive Supranuclear Palsy, and Corticobasal SyndromeAna Maria Rivas-Grajales, Steve C Han, Ryan Wang, et al.
Advances in Neurobiology|March 17, 2023
Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel TherapeuticsRudy Lozano Carreon, Ana Maria Rivas-Grajales, Nicholas Murphy, et al.
Journal of Affective Disorders|December 25, 2025
Electroconvulsive therapy is associated with a decrease in anhedonia and axial diffusivity in the medial forebrain bundle in major depressive disorderAna Maria Rivas-Grajales, Palig Mouradian, George Papadimitriou, et al.
The International Journal of Neuropsychopharmacology|November 29, 2020
Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant DepressionAna Maria Rivas-Grajales, Ramiro Salas, Meghan E Robinson, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|December 27, 2021
Ethical issues in the treatment of functional neurological disorderIvan R Molton, Eva Keatley, Abhishek Jaywant, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|December 19, 2023
Telemedicine-Based Cognitive Examinations During COVID-19 and Beyond: Perspective of the Massachusetts General Hospital Behavioral Neurology & Neuropsychiatry GroupKaloyan S Tanev, Joan A Camprodon, David N Caplan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Chronic Stress (Thousand Oaks, Calif.)|July 6, 2019
"Does the opioid system block or enhance the antidepressant effects of ketamine?"Sanjay J Mathew, Ana Maria Rivas-Grajales
CNS Spectrums|June 21, 2016
Psychosis of epilepsy: a multifaceted neuropsychiatric disorderAndres M Kanner, Ana Maria Rivas-Grajales
Expert Opinion on Investigational Drugs|October 15, 2019
Novel investigational therapeutics for generalized anxiety disorder (GAD)Bella Schanzer, Ana Maria Rivas-Grajales, Aamir Khan, et al.
Harvard Review of Psychiatry|May 12, 2023
The Impact of Sex Hormones on Transcranial Magnetic Stimulation Measures of Cortical Excitability: A Systematic Review and Considerations for Clinical PracticeAna Maria Rivas-Grajales, Tracy Barbour, Joan A Camprodon, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 10, 2025
L266V <i>MAPT</i> Gene Mutation Associated With Frontotemporal Dementia, Progressive Supranuclear Palsy, and Corticobasal SyndromeAna Maria Rivas-Grajales, Steve C Han, Ryan Wang, et al.
Advances in Neurobiology|March 17, 2023
Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel TherapeuticsRudy Lozano Carreon, Ana Maria Rivas-Grajales, Nicholas Murphy, et al.
Journal of Affective Disorders|December 25, 2025
Electroconvulsive therapy is associated with a decrease in anhedonia and axial diffusivity in the medial forebrain bundle in major depressive disorderAna Maria Rivas-Grajales, Palig Mouradian, George Papadimitriou, et al.
The International Journal of Neuropsychopharmacology|November 29, 2020
Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant DepressionAna Maria Rivas-Grajales, Ramiro Salas, Meghan E Robinson, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|December 27, 2021
Ethical issues in the treatment of functional neurological disorderIvan R Molton, Eva Keatley, Abhishek Jaywant, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|December 19, 2023
Telemedicine-Based Cognitive Examinations During COVID-19 and Beyond: Perspective of the Massachusetts General Hospital Behavioral Neurology & Neuropsychiatry GroupKaloyan S Tanev, Joan A Camprodon, David N Caplan, et al.
Pageof 1